Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA ’s efforts to foster discovery and development of new tools to fight antimicrobial-resistant infections

The increase in serious antimicrobial drug resistant infections is a critical public health concern and a growing threat to patients. FDA is taking steps to combat antibiotic-resistant bacteria.
Source: Food and Drug Administration - Category: American Health Source Type: news